328 related articles for article (PubMed ID: 17942028)
21. Complement immunofluorescence in sera of dogs with pemphigus foliaceus.
Medleau L; Dawe DL; Scott DW
Am J Vet Res; 1987 Mar; 48(3):486-7. PubMed ID: 3551700
[TBL] [Abstract][Full Text] [Related]
22. Case of pemphigus foliaceus that shifted into pemphigus vulgaris after adrenal tumor resection.
Awazawa R; Yamamoto Y; Gushi M; Taira K; Yagi N; Asato Y; Hagiwara K; Uezato H
J Dermatol; 2007 Aug; 34(8):549-55. PubMed ID: 17683386
[TBL] [Abstract][Full Text] [Related]
23. Case of pemphigus foliaceus misdiagnosed as a single condition of erythrodermic psoriasis and modified by brodalumab.
Morishima-Koyano M; Nobeyama Y; Fukasawa-Momose M; Kikuchi S; Asahina A
J Dermatol; 2020 May; 47(5):e201-e202. PubMed ID: 32124468
[No Abstract] [Full Text] [Related]
24. Pemphigus herpetiformis is a rare clinical expression of nonendemic pemphigus foliaceus, fogo selvagem, and pemphigus vulgaris. Cooperative Group on Fogo Selvagem Research.
Santi CG; Maruta CW; Aoki V; Sotto MN; Rivitti EA; Diaz LA
J Am Acad Dermatol; 1996 Jan; 34(1):40-6. PubMed ID: 8543693
[TBL] [Abstract][Full Text] [Related]
25. Who will develop pemphigus foliaceus?
Tzu J; Romagosa Y; Kirsner RS
J Invest Dermatol; 2009 Jan; 129(1):6. PubMed ID: 19078981
[No Abstract] [Full Text] [Related]
26. [D-penicillamine-induced pemphigus: changes in anti-32-2B immunostaining patterns].
Khashoggi M; Machet L; Perrinaud A; Brive D; Machet MC; Maruani A; Vaillant L
Ann Dermatol Venereol; 2013; 140(8-9):531-4. PubMed ID: 24034638
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to pilosebaceous units along their neurovascular supply routes in a new variant of endemic pemphigus foliaceus in Colombia, South America.
Abreu Velez AM; Yi H; Gao W; Smoller BR; Grossniklaus HE; Howard MS
Eur J Dermatol; 2011; 21(3):371-5. PubMed ID: 21543287
[TBL] [Abstract][Full Text] [Related]
28. Neutrophilic spongiosis in pemphigus.
Hoss DM; Shea CR; Grant-Kels JM
Arch Dermatol; 1996 Mar; 132(3):315-8. PubMed ID: 8607637
[TBL] [Abstract][Full Text] [Related]
29. Pemphigus vulgaris presenting in a radiation portal.
Robbins AC; Lazarova Z; Janson MM; Fairley JA
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S82-5. PubMed ID: 17434046
[TBL] [Abstract][Full Text] [Related]
30. Pemphigus foliaceus with neutrophilic spongiosis evolving to an atypical pemphigus phenotype.
Gabbi TV; Bernardelli IM; Santi CG; Maruta CW; Kodani V; Sotto MN; Li N; Hilario-Vargas J; Diaz LA; Rivitti EA; Aoki V
J Am Acad Dermatol; 2004 Dec; 51(6):1012-3. PubMed ID: 15583603
[TBL] [Abstract][Full Text] [Related]
31. Patients affected by a new variant of endemic pemphigus foliaceus have autoantibodies colocalizing with MYZAP, p0071, desmoplakins 1-2 and ARVCF, causing renal damage.
Abreu-Velez AM; Howard MS; Yi H; Florez-Vargas AA
Clin Exp Dermatol; 2018 Aug; 43(6):692-702. PubMed ID: 29768670
[TBL] [Abstract][Full Text] [Related]
32. Immunofluorescence study of pemphigus from north India.
Kumar S; Thappa DM; Sehgal S
J Dermatol; 1995 Aug; 22(8):571-5. PubMed ID: 7560454
[TBL] [Abstract][Full Text] [Related]
33. Paraneoplastic pemphigus: a subset of patients with pemphigus and neoplasia.
Mehregan DR; Oursler JR; Leiferman KM; Muller SA; Anhalt GJ; Peters MS
J Cutan Pathol; 1993 Jun; 20(3):203-10. PubMed ID: 8366210
[TBL] [Abstract][Full Text] [Related]
34. Erythroderma with pemphigus immunofluorescence. An erythrodermic variant of pemphigus?
Cozzani E; Balestrero S; Parodi A; Rebora A
Int J Dermatol; 1999 Mar; 38(3):207-8. PubMed ID: 10208618
[No Abstract] [Full Text] [Related]
35. Rapid transition from pemphigus vulgaris to pemphigus foliaceus.
Ito T; Moriuchi R; Kikuchi K; Shimizu S
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):455-7. PubMed ID: 25376758
[No Abstract] [Full Text] [Related]
36. [Pemphigus vegetans of the Hallopeau type. Detection of pemphigus antibodies with direct and indirect immunofluorescence].
Gerharz M; Stadler R
Hautarzt; 1987 Jun; 38(6):371-4. PubMed ID: 3308773
[TBL] [Abstract][Full Text] [Related]
37. Pemphigus foliaceus with prominent neutrophilic pustules initially presenting as erythroderma.
Miyakura T; Yamamoto T; Okubo Y; Ishii N; Oyama B; Hashimoto T; Tsuboi R
Clin Exp Dermatol; 2009 Jul; 34(5):e46-9. PubMed ID: 19438568
[TBL] [Abstract][Full Text] [Related]
38. Desmoglein1 and BP 180 ELISA indexes correlating with disease activity in a patient with coexisting pemphigus foliaceus and bullous pemphigoid.
Ando S; Sato-Matsumura KC; Kasai M; Nemoto-Hasebe I; Hoshina D; Ohyama B; Hashimoto T; Shimuzu H
Clin Exp Dermatol; 2009 Dec; 34(8):e995-6. PubMed ID: 20055881
[No Abstract] [Full Text] [Related]
39. Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceus.
Kallel Sellami M; Ben Ayed M; Mouquet H; Drouot L; Zitouni M; Mokni M; Cerruti M; Turki H; Fezza B; Mokhtar I; Ben Osman A; Zahaf A; Kamoun MR; Joly P; Masmoudi H; Makni S; Tron F; Gilbert D
Clin Exp Immunol; 2004 Jul; 137(1):195-200. PubMed ID: 15196262
[TBL] [Abstract][Full Text] [Related]
40. Generalized erythrodermic pemphigus foliaceus in a child and its successful response to rituximab treatment.
Connelly EA; Aber C; Kleiner G; Nousari C; Charles C; Schachner LA
Pediatr Dermatol; 2007; 24(2):172-6. PubMed ID: 17461818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
